AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its stake in shares of AdaptHealth Corp. (NASDAQ:AHCOFree Report) by 73.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 191,833 shares of the company’s stock after acquiring an additional 81,097 shares during the quarter. JPMorgan Chase & Co. owned about 0.14% of AdaptHealth worth $2,154,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of AHCO. Canada Pension Plan Investment Board acquired a new position in shares of AdaptHealth during the 2nd quarter valued at about $58,000. Quarry LP increased its position in AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after purchasing an additional 5,838 shares in the last quarter. CIBC Asset Management Inc acquired a new stake in AdaptHealth during the 3rd quarter worth approximately $122,000. MBB Public Markets I LLC acquired a new stake in AdaptHealth during the 2nd quarter worth approximately $142,000. Finally, LRI Investments LLC increased its position in AdaptHealth by 32.0% during the 3rd quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock worth $172,000 after purchasing an additional 3,713 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

Analysts Set New Price Targets

AHCO has been the subject of a number of research analyst reports. UBS Group dropped their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Royal Bank of Canada dropped their target price on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Canaccord Genuity Group dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Truist Financial decreased their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 15th. Finally, Robert W. Baird reduced their target price on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $12.40.

Check Out Our Latest Research Report on AHCO

AdaptHealth Trading Down 0.2 %

NASDAQ:AHCO opened at $10.50 on Wednesday. AdaptHealth Corp. has a 1-year low of $6.72 and a 1-year high of $11.90. The firm has a market capitalization of $1.41 billion, a price-to-earnings ratio of -6.36, a price-to-earnings-growth ratio of 1.36 and a beta of 1.09. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The stock has a fifty day simple moving average of $9.91 and a 200 day simple moving average of $10.36.

AdaptHealth (NASDAQ:AHCOGet Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.02). The firm had revenue of $805.90 million during the quarter, compared to analyst estimates of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The business’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 earnings per share. Sell-side analysts forecast that AdaptHealth Corp. will post 0.88 earnings per share for the current year.

AdaptHealth Profile

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

See Also

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.